CAMBRIDGE, Mass., Oct. 30, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Steven H. Holtzman, Chair and Chief Executive Officer, will be presenting a company overview at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference being held November 5-7, 2007 in New York. Infinity's presentation will take place on Tuesday, November 6, 2007, at 2:20 p.m. EST.
A live webcast of Infinity's presentation will be accessible on the company's website at http://www.ipi.com and will be archived on the website for 30 days.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. For more information on Infinity, please refer to the company's website at http://www.ipi.com. INFI-G